Vistra
US$ 29.66
bpc 157 multiple sclerosis clinical trial humans Frontiers Stable gastric pentadecapeptide BPC 157
Description
Pivotal Phase 3 trials Trial SURMOUNT-1 (NEJM 2022) Population 2,539 adults, obesity, no diabetes
Beyond the Injection: A Holistic Approach Injections work best as part of a broader health plan
No jitters
This space can feel like a gray area, says Dr
